| AS | Ankylosing spondylitis |
| BASDAI | Bath Ankylosing Spondylitis Disease Activity Index |
| BASFI | Bath Ankylosing Spondylitis Functional Index |
| BAS-G | Bath Ankylosing Spondylitis Patient Global Score |
| BD | Behcet disease |
| CA | citric acid group |
| CAL | clinical attachment loss |
| CSRG | Canadian Scleroderma Research Group |
| DAS 28 | disease activity score 28 |
| DMF-T | decayed-, missing-, and filled-teeth index |
| dSSc | diffuse systemic sclerosis |
| D-T | number of decayed teeth |
| EPSSRI | Emotional Problems Scales-Self Report Inventory |
| EGF | epidermal growth factor |
| GOHAI | general oral health assessment index |
| HAQ | health assessment questionnaire |
| HRQoL | health-related quality of life |
| ICC | intraclass correlation |
| lSSc | localized systemic sclerosis |
| MA | malic acid group |
| MHISS | mouth handicap in systemic sclerosis |
| M-T | number of missing teeth |
| n/a | not applicable |
| OHIP | oral health impact profile |
| OHRQoL | oral-health-related quality of life |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| pSS | primary Sjögren syndrome |
| RA | rheumatoid arthritis |
| RAPID3 | Routine Assessment of Patient Index Data 3 |
| SDI | SLICC damage index |
| SEM | standard error of measurement |
| SF-36 | short form 36 survey |
| SLE | systemic lupus erythematosus |
| SS | Sjögren Syndrome |
| sSS | secondary Sjögren Syndrome |
| SSc | Systemic sclerosis |
| T | Turkey |
| UK | United Kingdom |
| XeQoL | quality of life questionnaire in xerostomy |
| UK | United Kingdom |
| XeQoL | quality of life questionnaire in xerostomy |
| PICO | patient intervention control outcome |